DSC521 Pill - blue & white capsule/oblong, 19mm
Generic Name: pexidartinib
Pill with imprint DSC521 is Blue & White, Capsule/Oblong and has been identified as Turalio 125 mg.
Turalio is used in the treatment of Tenosynovial Giant Cell Tumor and belongs to the drug class multikinase inhibitors. Turalio 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DSC521
Turalio
- Generic Name
- pexidartinib
- Imprint
- DSC521
- Strength
- 125 mg
- Color
- Blue & White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Manufacturer
- Daiichi Sankyo, Inc.
- National Drug Code (NDC)
- 65597-0407
See also:
Romvimza
Romvimza is used to treat symptomatic tenosynovial giant cell tumor (TGCT) in adults when surgery ...
Alecensa
Alecensa (alectinib) is an oral kinase inhibitor that may be used to treat certain types of ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Alunbrig
Alunbrig (brigatinib) is used to treat anaplastic lymphoma kinase-positive (ALK+) metastatic ...
Augtyro
Augtyro (repotrectinib) is a next-generation TKI (Tyrosine Kinase Inhibitor) cancer medicine used ...
Ayvakit
Ayvakit (avapritinib) is a prescription medicine used for the treatment of gastrointestinal stromal ...
Balversa
Balversa (erdafitinib) is an oral kinase inhibitor that may be used to treat adults with locally ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
More about Turalio (pexidartinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.